Aurora Sample Clauses

Aurora. AURORA shall indemnify, defend and hold harmless PACKARD and its AFFILIATES, and the directors, officers, employees, agents and counsel of PACKARD and such AFFILIATES, and the successors and assigns of any of the foregoing (the "PACKARD Indemnitees"), from and against any and all liabilities, damages, losses, costs or expenses (including reasonable attorneys' and professional fees and other expenses of litigation and/or arbitration) resulting from a claim, suit or proceeding brought by a third party against a PACKARD Indemnitee, arising from or occurring as a result of (a) activities performed by AURORA in the Collaboration Program, except to the extent caused by the negligence or willful misconduct of a PACKARD Indemnitee; or (b) use by PACKARD of AURORA TECHNOLOGY (other than patent rights subject to the UC LICENSE as to which no indemnification is provided); or (c) the use by PACKARD of, or the manufacture or commercialization by PACKARD of, any AURORA REAGENTS (other than AURORA UC REAGENTS as to which no indemnification is provided) or any PRODUCT to the extent it embodies AURORA TECHNOLOGY (other than patent rights subject to the UC LICENSE as to which no indemnification is provided).
AutoNDA by SimpleDocs
Aurora. As of the Effective Date, Aurora represents and warrants that: (i) it has the full legal power, authority, and right to enter into this Agreement, and to perform all of its obligations hereunder; (ii) it has the legal right and power to extend the rights to Allelix granted in this Agreement; and (iii) to the best of its knowledge as of the Effective Date, there are no existing or threatened actions, suits, or claims pending against it with respect to the Aurora Technology.
Aurora. Aurora agrees to indemnify, defend, and hold Allelix, its Affiliates, Licensors and Licensees, and the directors, officers, employees, and agents of each of them (the "Allelix Indemnitees") harmless from and against any Liabilities arising out of or in connection with Third Party claims relating to ***
Aurora. Vendor's Principal Place of Business (State) In what state is Vendor's principal place of business located? IL
Aurora. Xxxxxx shall timely meet each milestone identified as an Aurora milestone in Attachment I to Appendix F (the “Aurora Milestones”). Appendix F sets forth remediation actions in the event Xxxxxx fails to meet an Xxxxxx Xxxxxxxxx in accordance with the timeline in Appendix F. Aurora shall promptly notify Continental in writing if it reasonably believes it will be unable to achieve any Aurora Milestone, as soon as commercially reasonable, not to exceed within five (5) Business Days after coming to this belief.
Aurora. The names of certain Personnel of Xxxxxx are identified on Appendix L (the “Aurora Key Personnel”) together with an indication whether they will be assigned full-time or part-time to work under this Agreement. Without Continental’s prior written consent, which shall not be unreasonably withheld: Xxxxxx shall not remove any Aurora Key Personnel from their work, or materially reduce their responsibilities for work, under this Agreement. If one of the Aurora Key Personnel ceases to be employed by Xxxxxx, or becomes incapacitated or otherwise unavailable to perform the functions or responsibilities assigned to him or her under this Agreement, then Xxxxxx shall promptly replace this person with another Aurora employee who is similarly qualified as the person who is being replaced. For purposes of this Section, the movement of Aurora Key Personnel from the employ of Aurora to an Affiliate of Aurora that results in an alteration or reduction of time expended by that person in performance of Xxxxxx’s duties under this Agreement, will be considered a removal requiring Continental’s consent and not a cessation of employment. Notwithstanding the foregoing, Continental’s consent shall not be required for Aurora to assign, reassign, or otherwise move Aurora Key Personnel or any other employees due to immigration or visa related reasons, provided that such assignment, reassignment or move shall be subject to the requirements set forth in this Section 13.2.
Aurora. Upon receipt of a [***] from Hyseq, Aurora will initiate [***] will be assessed by [***], will be screened against the [***]. Recent results from [***] have shown that [***]; Hyseq will supply to Aurora [***]. Validation of the [***], will be complete once Aurora shows that [***]. - Option: Aurora will [***], for delivery of [***], with the understanding by all parties that inability to subsequently remove such a tag may alter the biological activity of the OSP. Aurora will then use [***] in dose-response tests against [***]. - Aurora will provide to Hyseq a [***]. Aurora will also provide to Hyseq the [***] (if that option is undertaken). A copy of a [***] that Aurora typically submits to a partnering company is being provided to Hyseq. APPENDIX I- CELLSENSOR ASSAYS RELEVANT FOR OSP SCREENING ----------------------------- -------------------- --------------------------- CELL LINE PATHWAY MEASURED REFERENCE STIMULUS ----------------------------- -------------------- --------------------------- [***] [***] [***] ----------------------------- -------------------- --------------------------- [***] [***] [***] ----------------------------- -------------------- --------------------------- [***] [***] [***] ----------------------------- -------------------- --------------------------- [***] [***] [***] ----------------------------- -------------------- --------------------------- [***] [***] [***] ----------------------------- -------------------- --------------------------- [***] [***] [***] ----------------------------- -------------------- --------------------------- [***] [***] [***] ----------------------------- -------------------- --------------------------- [***] [***] [***] ----------------------------- -------------------- --------------------------- [***] [***] [***] ----------------------------- -------------------- --------------------------- [***] [***] [***] ----------------------------- -------------------- --------------------------- [***] [***] [***] ----------------------------- -------------------- --------------------------- CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. ----------------------------- -------------------- --------------------------- [***] [***] [***] ----------------------------- -------------------- --------------------------- [***] [***...
AutoNDA by SimpleDocs
Aurora. In concert with Hyseq personnel, Aurora will [***]. The timing for target selection will be phased, in [***] intervals. At the time of the first JRDC meeting, Aurora will inform Hyseq of the [***] after this date, Aurora will [***], and provide to Hyseq (at the next JRDC meeting) a newly prioritized target list. This process will [***], during the term of the contact, until at least [***]. - In addition, Aurora can select [***]. - Upon receipt of the [***], Aurora will deploy these [***]. - [***]. - Aurora will consider a [***]. This set of [***] It is expected that a [***]. Two reasons for this are: (1) Aurora will [***], and (2) the scope of the current [***] - [***], Aurora will provide to Hyseq update reports on the activities identified using the [***]. These reports will contain data for each selected target on (1) development of a [***]. APPENDIX II - ASSAY VALIDATION. [***] CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.
Aurora. As of the Effective Date, Aurora represents and warrants that:
Time is Money Join Law Insider Premium to draft better contracts faster.